Pfizer Faces Setbacks In Patent Battle Over Viagra
Pfizer has met with setbacks in Canada and the U.S. its effort to protect in its $1.7 billion erectile dysfunction drug Viagra from competition from Eli Lilly's Cialis....To view the full article, register now.
Already a subscriber? Click here to view full article